Back to Search
Start Over
688P Pharmacokinetics of HMBD-001, a human monoclonal antibody targeting HER3, a CRUK first-in-human phase I trial in patients with advanced solid tumours.
- Source :
-
Annals of Oncology . 2023 Supplement 2, Vol. 34, pS480-S480. 1p. - Publication Year :
- 2023
- Subjects :
- *MONOCLONAL antibodies
*PHARMACOKINETICS
*TUMORS
*HUMAN beings
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 34
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 173098743
- Full Text :
- https://doi.org/10.1016/j.annonc.2023.09.1874